Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tedizolid Phosphate vs Linezolid in Japanese Patients with MRSA Infections
NCT01967225Phase 3Completed
- Sponsor
- Bayer
- Start
- Nov 2013
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tedizolid in skin and soft tissue infection (SSTI), Bacteremia, sponsored by Bayer. Started Nov 2013; status: completed.
02
Drugs
tedizolid
03
Conditions
skin and soft tissue infection (SSTI)Bacteremia
Beyond the preview
Go deeper on NCT01967225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01967225.